Ozempic Lawsuit Massachusetts
Attorney Tracy Paulsen is a Massachusetts GLP-1 lawsuit lawyer who can evaluate potential claims involving serious injuries alleged to be associated with Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, Zepbound, and other GLP-1 medications. A diagnosis alone does not establish liability.
- Understand the process of making a GLP-1 injury claim
- File a claim
- Tell the story of you and your injury to the court and/or jury.
- Answer your questions about the process and timeline for your recover. 3
FDA Update: New NAION Warning Required for GLP-1 Medications — November 2026
On November 9, 2026, the FDA announced that manufacturers of all GLP-1 receptor agonist medications must add information about a potential increased risk of non-arteritic anterior ischemic optic neuropathy (NAION) to the Warnings and Precautions section of their prescription labeling. The requirement covers Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, Zepbound, and other medications in the class. NAION is a rare condition that can cause sudden, painless vision loss, sometimes permanently.
The FDA reviewed clinical trials, postmarketing reports, and observational research. Its analysis of 126 randomized trials found NAION rates of 6.4 per 100,000 person-years among GLP-1 users and 3.8 among comparison patients. Other analyses had mixed findings. The FDA concluded that the potential risk warrants a warning, not that every reported case was caused by a medication.
For Massachusetts patients considering a lawsuit, the new requirement may be relevant to whether earlier drug warnings were adequate and what information manufacturers had about the risk. It does not automatically establish causation, negligence, or a right to compensation. Sudden vision changes require urgent medical evaluation; discuss medication changes with your healthcare professional.
FDA Drug Safety Communication (November 9, 2026)
What type of injuries are being investigated in GLP-1 lawsuits?
HEALTH ISSUES REPORTED WITH GLP-1 MEDICATIONS
Despite the popularity of GLP-1 medications such as Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, and Zepbound, serious adverse events have been reported. Whether a particular injury was caused by a drug requires medical evidence; reported conditions are not all established side effects.
- Cancer
- Cyclic Vomiting Syndrome,
- Chronic vomiting
- Ileus (temporary bowel movement halt)
- Malnutrition related disorders
- Deep vein thrombosis
- Esophageal injury
- Intestinal blockages
- Non-arteritic anterior ischemic optic neuropathy (NAION)/Blindness
- Gastroparesis (stomach paralysis)
- Gastric obstruction
- Gallbladder disease and gallstones
If you experience any of these conditions from GLP-1 medication, Attorney Paulsen can help you recover money and join the lawsuits regarding this drug.
If you have been diagnosed with a serious condition after taking a GLP-1 medication, Attorney Paulsen can review whether the available evidence supports a claim.
Why Work with Attorney Paulsen
Attorney Tracy Paulsen is a Massachusetts GLP-1 medication Lawyer that has spent her career trying to protect the Rights of individuals. Rightful Legal was created as a result of her passion to protect the ability of individual to enjoy their best life; Ozmpic is a drug that prays on insecurities and an obsession to be thin in our culture and exposed so many people to unthinkable injuries and suffering.
Attorney Paulsen believes:
- You should have never been injured;
- You should not be going through this
- And that the only way to create change and to make your life better is through filing a lawsuit and using the Court system to protect your rights.
No one wants to file a lawsuit—but Attorney Tracy Paulsen believes that the Court system levels the playing field between the corporation and individual and is your only avenue of justice. Attorney Paulsen will do the complex legal work to get you the money you are entitled to as a result of consuming Ozympic and being seriously injured.
Did You Suffer Stomach Paralysis After Taking a GLP-1 Medication?
GASTROPARESIS (STOMACH PARALYSIS)
- Attorney Tracy Paulsen can help you if you suffered Gastoparesis— also known as Stomach Paralysis.
One of the most common claims tied to Ozempic is stomach paralysis, also called gastroparesis. This is a dangerous medical condition that slows down or even paralyzes stomach and intestinal muscles, preventing the normal movement of food through the body. Gastroparesis can be a debilitating condition, the symptoms of which include:
- Severe nausea and vomiting
- Abdominal pain and bloating
- Loss of appetite and weight loss
- Malnutrition and dehydration
- Difficulty eating and absorbing nutrients
The effects of gastroparesis can be so severe that that surgical intervention is necessary to address the issue. Severe gastroparesis cases may require feeding through a jejunostomy tube, which is a tube placed through the skin of the abdomen into the midsection of the small intestine.
THE GLP-1 LAWSUIT
Why Might GLP-1 Drug Manufacturers Be Legally Responsible for Injuries?
Attorney Tracy Paulsen is passionate about using the legal system to hold companies accountable when the evidence supports a claim. Ozempic lawsuits allege that manufacturers failed to provide adequate warnings about certain serious risks. Whether a manufacturer is legally responsible depends on the specific injury, warning history, causation evidence, and applicable law.
What Is a Failure to Warn in a Massachusetts GLP-1 Lawsuit?
A failure to warn is when a Company puts a product into the market with harmful potential side effects that were not disclosed to the user of the drug. Drug companies have a duty to warn the user about potential adverse side effects, before a drug can be marketed to consumers. The companies have a duty to investigate and research all the possible side effects that a drug like Ozempic can cause.
- Drug manufacturers are required to disclose known side effects and health risks associated with their products, working in conjunction with the FDA.
Side effects of Ozempic include nausea, vomiting and even thyroid tumors. In September 2023, the FDA ordered that intestinal blockage be added to the list of side effects for Ozempic. After this time, the first lawsuits were filed over the safety of Ozempic suggesting a link between the drugs and severe gastrointestinal problems, like gastroparesis and gastric obstruction. The FDA has not added an official warning for these side effects.
The FDA has now required a NAION warning for GLP-1 medications. This is a separate regulatory development from the gastrointestinal allegations discussed above. A new warning can be relevant to a failure-to-warn claim, but does not by itself prove an earlier warning was legally inadequate.
What Allegations Are Being Made in GLP-1 Lawsuits?
The GLP-1 Lawsuit claims that the drug manufacturers were aware or should have been aware of these side effects and did not inform the public or the medical community, and therefore failed to provide adequate warnings of the health risks associated with these drugs.
- Federal GLP-1 gastrointestinal injury lawsuits have been coordinated in MDL No. 3094 in the Eastern District of Pennsylvania since 2024. Separately, federal lawsuits alleging NAION vision loss were centralized in MDL No. 3163 in December 2025. An MDL coordinates pretrial proceedings; it is not the same as a class action, and individual claims remain separate. The FDA’s November 2026 NAION warning may be relevant in MDL 3163 but does not resolve its disputed issues.
Schedule a call with GLP-1 lawsuit lawyer Tracy Paulsen to discuss whether you may qualify.
GLP-1 LAWSUIT ELIGIBILITY
Contact Attorney Paulsen and the Massachusetts GLP-1 injury attorneys at Rightful Legal if you or a loved one experienced a serious injury after using a GLP-1 medication.
- Used a GLP-1 medication, such as Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, or Zepbound; medication-specific screening criteria may apply.
- Were diagnosed with Gastroparesis or Stomach Paralysis or Gastric Obstruction while taking the drug or within 30 days of stopping;
- Stopped taking the drug at the time of injury diagnosis;
- You required an emergency room visit and/or were admitted to the hospital; and
- You are within the statute of limitations for your particular state, meaning the time frame required bring a product liability lawsuit in your state has not lapsed or is soon approaching.
- These existing screening factors concern primarily gastrointestinal claims. They are not universal eligibility requirements for NAION vision-loss claims. Patients diagnosed with NAION after GLP-1 use may request a case evaluation even if they did not stop the drug at diagnosis or require hospitalization.
- Contact a GLP-1 attorney at Rightful Legal today to discuss whether you can bring a claim.
WHAT DAMAGES ARE AVAILABLE IN AN OZEMPIC LAWSUIT?
Those who bring supported GLP-1 injury claims may be able to recover compensation for documented losses, depending on applicable law:
- Medical expenses
- Lost wages
- Loss of quality of life
- Loss of consortium
- Emotional and physical pain and suffering
- Wrongful death
- Other economic and non-economic damages
DO I NEED AN ATTORNEY FOR A GLP-1 LAWSUIT?
If you have suffered health issues due to taking Ozempic you could be entitled to substantial compensation for what you’ve suffered. Instead of hoping that Novo Nordisk will do the right thing or trying to pursue your claim alone, it is vital for you to get legal help of your own. It is also important to evaluate whether medical malpractice was involved. An experienced Products Liability Lawyer or Defective Drug Lawyer can evaluate your case, gather evidence, calculate your losses, file the appropriate paperwork, negotiate a fair settlement and help you take your case to trial if needed. It is important to bring forth a claim as soon as possible.
If you have watched the news or browsed the internet lately, you have likely seen stories of the success of Ozempic and Ozempic-like drugs in treating type-2 diabetes, but more so as the miracle drug which helps those suffering from obesity to lose significant amounts of weight, in a short period of time. As with any drug, there is a downside and a risk. These drugs, known as GLP-1 receptor agonists, are no different, and have caused many individuals serious harm and complications from regular use.
Rightful Legal, a Massachusetts-based personal injury firm, evaluates potential serious injury claims involving GLP-1 medications, including Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, and Zepbound.
WHAT ARE GLP-1 RECEPTOR AGONISTS?
Ozempic, the brand name for an injectable semaglutide was approved for use by the FDA in 2017 initially for the treatment of type-2 diabetes.
History of GLP-1 Medications
Rybelsus, the oral semaglutide product, was approved in 2019; Ozempic is an injectable semaglutide product. Additional medications included in this page: Trulicity (dulaglutide), Mounjaro and Zepbound (tirzepatide).
These drugs quickly became knows to achieve significant results.
Ozempic, Rybelsus and Wegovy contain semaglutide; Trulicity contains dulaglutide; Mounjaro and Zepbound contain tirzepatide, a dual GIP/GLP-1 receptor agonist. These medications are related but are not identical, and their approved uses and warnings can differ.
Patients who discontinue the use of these drugs will often gain weight back. This is because the mechanisms that helps control appetite and regulate weight may no longer be active. It is important to note, that long-term use does not come without risks.
REACH OUT TO ATTORNEY PAULSEN TO DISCUSS A POSSIBLE GLP-1 INJURY CLAIM.
Contact our GLP-1 lawsuit lawyers today for a free consultation to discuss whether you or a loved one may have a claim.
If you or a loved one has taken a GLP-1 medication, including Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro or Zepbound, and experienced serious adverse effects, contact Rightful Legal at 617-821-5856.
Frequently Asked Questions About Massachusetts GLP-1 Lawsuits
The FDA required manufacturers of GLP-1 receptor agonists to add information about a potential increased risk of NAION to the Warnings and Precautions section of their labeling.
Yes. The FDA’s class-wide announcement includes Mounjaro and Zepbound, which contain tirzepatide, as well as semaglutide products such as Ozempic, Wegovy, and Rybelsus.
No. The warning concerns a potential increased risk. A lawsuit still requires evidence addressing the diagnosis, medication exposure, causation, and legal responsibility.
Possibly. Massachusetts residents may have claims involving alleged drug-related injuries, but the applicable law, filing location, and deadline depend on the facts.
MDL 3094 coordinates GLP-1 gastrointestinal and related injury litigation. MDL 3163 separately coordinates federal lawsuits alleging GLP-1 medications caused NAION vision loss.
A claim may still be possible. The new warning does not automatically prove earlier warnings were inadequate or restart the applicable filing deadline.
Keep pharmacy and prescription records, medication names and doses, medical and eye examination records, relevant diagnostic testing, and documentation of financial losses.
Massachusetts generally has a three-year limitations period for many personal injury claims, but drug product cases can involve different legal and factual issues. An attorney should evaluate the actual deadline rather than assuming it runs from the FDA announcement.


